Since the development of satisfactory methods of determining the phospholytic activity of the blood by Kay (1, 2) and by Bodansky and others (3, 4, 5, 6) , there has been increasing interest in the relation of blood phosphatase to various pathological conditions. It is now fairly well established that the major portion of the phosphatase in the blood is contained in the erythrocytes (1, 7, 8, 9, 10) . Of the phosphatase in the serum, a part may well originate in the bones, and a part in the liver, kidney, and intestinal mucosa (11, 12) , as these tissues are rich in phosphatase. The serum phosphatase of non-osseous origin is raised by ingestion of carbohydrates, greatly raised by obstructive jaundice, and lowered by starvation and by the ingestion of proteins (13, 14, 15, 16, 17) . The serum phosphatase of osseous origin is greatly increased in bone diseases associated with excessive bone and osteoid formation (1, 4, 18, 19, 20, 21) .
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The rise in serum phosphatase in some types of bone tumors is apparently due to the production of large quantities of the enzyme by the neoplastic tissue or adjacent periosteum, and the removal of part of the enzyme by the blood stream. It has been reported by Kay (1), Bodansky and Jaffe (4), Simmons and Franseen (20, 21) and others that this increase in serum phosphatase is of use in the diagnosis of bone cancer, and that serial determinations made during the course of treatment are important in prognosis. In the present paper further evidence on these questions is presented. METHOD We have used Bodansky's modification of Kay's procedure with some changes (2, 3) . Fifteen cc. of blood were allowed to clot for ½ to 1 hour, and centrifuged. The serum was then decanted and centrifuged again to remove all cells. One cc. of serum was then added to 9 cc. of sodiumbeta-glycerophosphate and sodium barbiturate buffer, and incubated for 20 minutes to 2 hours, the time depending on the phospholytic activity anticipated. A sample was then withdrawn for pH determination, and 10 per cent trichloracetic acid was added to the remainder of the mixture.
Meanwhile, 1.5 cc. of serum had been added to 13.5 cc. of 5 per cent trichloracetic acid for inorganic phosphorus determination. The trichloracetic acid precipitates were removed by filtration, and the inorganic phosphorus in the filtrate determined colorimetrically by means of molybdic and sulphuric acid and stannous chloride, all determinations being run in duplicate.
Two modifications of Bodansky's procedure were introduced. The first was made because we were unable to obtain blank solutions of molybdic and sulphuric acids and stannous chloride which were free from color. Accordingly we prepared 3 blanks, (B1) containing the color reagents molybdic and sulphuric acids and stannous chloride in the concentration in which they appeared in the standard phosphate solution; (B2) containing the color reagents, substrate, and trichloracetic acid in the same concentration as for the phosphatase determination; (B2) containing color reagents and trichloracetic acid in the same concentration as for the determination of inorganic phosphorus. The apparent phosphorus concentrations of these blanks were then read against the standard and applied as correction to the standard and unknown solutions. It was found that, when this was done, the deviation from Beer's law in known standard phosphate solutions of different concentrations was very much less than that reported by Bodansky. The correction for substrate plus trichloracetic acid was less than Bodansky's for low phosphorus concentrations and greater for high concentrations. The The pH was determined by means of thymol blue in a Myers bicolorimeter at room temperature with a precision of ± 0.02 pH. The third wedge in the colorimeter was filled with potassium dichromate solution and was adjusted to match the color of each serum-substrate mixture. Preliminary work was also done with phenolphthalein and cresol red as indicators. The pH values with different indicators were not the same, there evidently being an unknown error due to substrate, serum proteins, or both. As we did not have facilities for checking the pH potentiometrically the pH readings reported here, while consistent with themselves, may contain a systematic error.
The pH of the serum-substrate mixture was found to fall somewhat during incubation, presumably owing to the liberation of phosphoric acid by the phosphatase. For 33 determinations the average pH change was -0.09 pH. The pH change was greater the higher the initial pH and the greater the phospholytic activity, but the changes observed were too near the experimental error of the method for exact study of these relationships.
Bodansky (22) Figures 1 and 2 . In women, the menstrual cycle does not appear to influence the serum phosphatase. The effect of various therapeutic agents will be considered later.
Belfanti et al. (23) have found that the phosphatase of rabbit liver and kidney is at its maximum activity at pH 4.5, while the phosphatase of bone is at its maximum at pH 9.0. Roche (9, 10) and Kay (1) report that the pH of maximum activity for the phosphatase of serum and of leukocytes is about 9.0, and that of erythrocytes about 6.0. Since the phosphatase of serum probably originates from several sources, and since the work of Franseen et al. (20, 21) and the early work of Kay (1) The average value of the ratio for 59 sera for which the phospholytic activity at pH 8.6 was normal (equal to or less than 4.0 units) was 2.2; the average value of the ratio for 52 sera having more than 4.0 units of phosphatase at pH 8.6 was also 2.2. There was considerable variation in the ratios in both groups. There was not, however, any evidence that the sera with high phospholytic activity contained an enzyme having an optimum at a different pH from the sera of low phospholytic activity. Investigation over a wider pH range might, of course, show such a difference, but this seems unlikely since the degree of elevation of serum phosphatase in disease, which has been reported by investigators working at pH 7.6 and those working at pH 8.6, has been about the same.
The degree of activation of the enzyme was also studied by the addition of magnesium as magnesium chloride to a final concentration of 0.005 M. It was found that the activity of the serum phosphatase was increased an average of 22 per cent in 34 determinations. This is in harmony with the findings of Kay and others (1, 24) . The effect of magnesium was slightly greater in the higher pH range, but there was no significant difference between normal and pathological sera. Thus the effect of magnesium does not seem to be of diagnostic significance.
The diagnostic value of phosphatase determination. The results of phosphatase determinations made for diagnostic purposes are summarized in the accompanying tables. Figures for serum calcium and inorganic phosphorus were normal in all cases except those of generalized osteitis fibrosa cystica, and hence are omitted except in those cases. Table I shows the figures for serum phosphatase in normal individuals, in cases of malig- Of the 20 cases with benign bone tumors and osteomyelitis, only one (Case 20) showed an elevated serum phosphatase. This was an aggressive giant cell tumor which was laying down bone. This suggests that the bone forming characteristics of a tumor are of more importance than its malignancy in determining whether its presence will give rise to an elevated serum phosphatase. (20, 21) . On the other hand, if the tumor present is one such as endothelial myeloma, which is not a source of excessive phosphatase, its removal should not affect the serum phosphatase. We have studied a number of cases during therapy in the hope that serial phosphatase determinations would prove to be a reliable guide in prognosis.
It was necessary first to determine whether the therapeutic procedures, operation, irradiation, and the administration of Coley's toxins, would in themselves influence the serum phosphatase. Accordingly we made serial determinations on fifteen patients whose initial serum phosphatase was normal or only slightly raised. The observations for two typical cases are shown in Figures 3 and  4 . The phosphatase was not significantly raised in any case following irradiation alone. The slight drop in phosphatase observed in two cases following irradiation may have been due to treatment, but was too small to be of much significance. Irradiation alone, therefore, appears to be without effect on normal phosphatase. In one case in this series where operation was followed by the administration of toxins, and in one case where irradiation was followed by the administration of toxins, there was a marked rise in phosphatase. In the cases with a high initial reading, which are discussed more fully later, there was a marked rise in phosphatase in two cases following operation and the administration of toxins and in two cases following irradiation and injection of toxins. It seems probable, though the rise in phosphatase during toxin therapy is not constant, that phosphatase determinations made during a course of toxins are without significance in prognosis.
The effect of operation is difficult to evaluate.
Bodansky and Jaffe (4) have reported a drop in serum phosphatase following operations not involving bone, but this may have been due to poor nutrition during the postoperative period. Since we have observed a slight rise in serum phosphatase on 3 occasions following bone operations, and since Hunsberger and Ferguson (26) and Smith and Maizels (18) have shown that there is a rise in serum phosphatase during the healing of fractures, it is likely that the serum phosphatase may be somewhat elevated following any operative procedure involving considerable bone trauma.
The second series of charts, Figures 5 to 11 inclusive, shows the changes during treatment in ing effect of magesium or in pH of optimum activity. The serum phosphatase was found to be normal or very slightly raised in chronic osteitis, osteomyelitis, benign bone tumors, endothelial myeloma, and chondrosarcoma, and high in osteitis deformans, generalized osteitis fibrosa cystica, osteoplastic metastatic disease, and some cases of osteogenic sarcoma, particularly those in which there is radiographic evidence of considerable bone production.
Serum phosphatase determinations were not found to be of value in detecting pulmonary metastases.
